Completed NA INTERVENTIONAL 2-arm NCT01708447

Feasibility Study: Evaluate the Effectiveness of Using a Topical Anesthetic Prior to Ultherapy™ Treatment

Feasibility Study: Evaluation of the Efficacy of a Liposome-encapsulated Lidocaine Topical Anesthetic for Reducing Discomfort Associated With Ultherapy™ Treatment

Sponsor: Ulthera, Inc

Conditions Skin Laxity

Interventions A placebo cream L.M.X.4.® cream Ulthera System Treatment

Updated 8 times since 2017 Last updated: Nov 21, 2017 Started: Jul 31, 2011 Primary completion: Dec 31, 2011 Completion: Jan 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Skin Laxity, this trial is completed. The trial is conducted by Ulthera, Inc and has accumulated 8 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2018 — Jun 2018 [monthly]

Completed NA

▶ Show 3 earlier versions

Dec 2017 — Feb 2018 [monthly]

Completed NA
Feb 2017 — Dec 2017 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Jul 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ulthera, Inc

Data source: Merz North America, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Phoenix, United States